| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 69.977 | 151.996 | 199.613 | 225.192 | 241.464 | 271.305 | 303.965 |
| Total Income - EUR | - | - | - | 69.977 | 151.998 | 199.758 | 225.195 | 241.468 | 271.307 | 303.966 |
| Total Expenses - EUR | - | - | - | 68.059 | 136.760 | 174.463 | 193.682 | 221.621 | 234.907 | 274.200 |
| Gross Profit/Loss - EUR | - | - | - | 1.918 | 15.238 | 25.295 | 31.513 | 19.847 | 36.400 | 29.766 |
| Net Profit/Loss - EUR | - | - | - | 1.219 | 13.718 | 23.299 | 29.791 | 17.534 | 33.692 | 25.003 |
| Employees | - | - | - | 2 | 2 | 2 | 3 | 3 | 3 | 3 |
Check the financial reports for the company - Farmacia Terapyfarm S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 70 | 27.431 | 23.189 | 19.036 | 14.995 | 11.311 | 35.305 |
| Current Assets | - | - | - | 63.779 | 95.458 | 99.269 | 107.696 | 106.360 | 123.552 | 120.648 |
| Inventories | - | - | - | 35.993 | 48.977 | 51.684 | 56.747 | 55.273 | 59.036 | 54.459 |
| Receivables | - | - | - | 25.506 | 29.937 | 36.155 | 38.941 | 45.663 | 44.674 | 43.835 |
| Cash | - | - | - | 2.281 | 16.544 | 11.430 | 12.007 | 5.423 | 19.842 | 22.355 |
| Shareholders Funds | - | - | - | 1.262 | 14.955 | 37.970 | 66.913 | 71.208 | 94.686 | 109.391 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 62.588 | 107.934 | 84.488 | 59.819 | 50.147 | 40.177 | 46.562 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4773 - 4773" | |||||||||
| CAEN Financial Year |
4773
|
|||||||||
Comments - Farmacia Terapyfarm S.r.l.